glutathione bromopyruvic acid conjugate 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis A, 3-bromopyruvate (3BP) targets critical
A, 3 bromopyruvate (3BP) targets critical steps in cancer cell biology. Download Scientific Diagram Phase II Glutathione Conjugation Metabolism of Herbicides or Xenobiotics in Plants passel The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect Glutathione Mediated Conjugation of Anticancer Drugs Encyclopedia MDPI
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


